Cabilatazan, Ricky C.

HRN: 25-51-26  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/22/2024
CEFUROXIME 750MG (VIAL)
08/22/2024
08/28/2024
IV
750mg
TID
Infected Wound PAOD
Waiting Final Action 
08/27/2024
CEFUROXIME 1.5GM (VIAL)
08/27/2024
09/03/2024
IV
1.5 G
Every 8 Hours
Infected Wound
Waiting Final Action 
08/27/2024
AZITHROMYCIN 500MG TABLET (TAB)
08/27/2024
08/31/2024
ORAL
500mg
Daily
Infected Wound
Waiting Final Action 
08/30/2024
CEFUROXIME 1.5GM (VIAL)
08/30/2024
09/06/2024
IV
1.5 G
Q8h
Dm Foot
Waiting Final Action 
09/05/2024
CEFTRIAXONE 1G (VIAL)
09/05/2024
09/09/2024
IV
1g
Q12
S/P Ray Amputation 3rd, 4th, 5th Digit Left Foot
Waiting Final Action 
09/05/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/05/2024
09/10/2024
IV
600mg
Q8
S/P Ray Amputation 3rd, 4th, 5th Digit Left Foot
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: